This SuperSeries is composed of the SubSeries listed below.
Overall design: Refer to individual Series
| Accession | PRJNA285076; GEO: GSE69279 |
| Type | Umbrella project |
| Publications | - Decock A et al., "Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma.", Oncotarget, 2016 Jan 12;7(2):1960-72
- Decock A et al., "DNA methylation profiling of primary neuroblastoma tumors using methyl-CpG-binding domain sequencing.", Sci Data, 2016 Feb 2;3:160004
|
| Submission | Registration date: 27-May-2015
Center for Medical Genetics, Ghent University |
| Relevance | Superseries |
Project Data:
| Resource Name | Number
of Links |
|---|
| Sequence data |
| SRA Experiments | 162 |
| Publications |
| PubMed | 2 |
| PMC | 2 |
| Other datasets |
| BioSample | 162 |
| GEO DataSets | 4 |
Methyl-CpG-binding domain (MBD) sequencing of neuroblastoma tumors encompasses the following 3 sub-projects:
| Project Type | Number of Projects |
| Epigenomics | 3 |
BioProject
accession | Organism | Title |
|---|
| PRJNA284948 | Homo sapiens | Methyl-CpG-binding domain (MBD) sequencing of 42 primary neuroblastoma tumors (Center for Medical Genetics,...) | | PRJNA285052 | Homo sapiens | Methyl-CpG-binding domain (MBD) sequencing of 45 primary neuroblastoma tumors (Center for Medical Genetics,...) | | PRJNA285075 | Homo sapiens | Methyl-CpG-binding domain (MBD) sequencing of 15 primary stage 4S neuroblastoma tumors (Center for Medical Genetics,...) |
|